200 related articles for article (PubMed ID: 3662452)
1. Acetylcholine receptors in human thymic myoid cells in situ: an immunohistological study.
Schluep M; Willcox N; Vincent A; Dhoot GK; Newsom-Davis J
Ann Neurol; 1987 Aug; 22(2):212-22. PubMed ID: 3662452
[TBL] [Abstract][Full Text] [Related]
2. Reflections on the "intrathymic pathogenesis" of myasthenia gravis.
Hohlfeld R; Wekerle H
J Neuroimmunol; 2008 Sep; 201-202():21-7. PubMed ID: 18644632
[TBL] [Abstract][Full Text] [Related]
3. The thymus in myasthenia gravis. Changes typical for the human disease are absent in experimental autoimmune myasthenia gravis of the Lewis rat.
Meinl E; Klinkert WE; Wekerle H
Am J Pathol; 1991 Nov; 139(5):995-1008. PubMed ID: 1951638
[TBL] [Abstract][Full Text] [Related]
4. Autoimmunizing mechanisms in thymoma and thymus.
Willcox N; Leite MI; Kadota Y; Jones M; Meager A; Subrahmanyam P; Dasgupta B; Morgan BP; Vincent A
Ann N Y Acad Sci; 2008; 1132():163-73. PubMed ID: 18567866
[TBL] [Abstract][Full Text] [Related]
5. Expression of acetylcholine receptor genes in human thymic epithelial cells: implications for myasthenia gravis.
Wakkach A; Guyon T; Bruand C; Tzartos S; Cohen-Kaminsky S; Berrih-Aknin S
J Immunol; 1996 Oct; 157(8):3752-60. PubMed ID: 8871679
[TBL] [Abstract][Full Text] [Related]
6. Specific activation of lymphocytes against acetylcholine receptor in the thymus in myasthenia gravis.
Fujii Y; Hashimoto J; Monden Y; Ito T; Nakahara K; Kawashima Y
J Immunol; 1986 Feb; 136(3):887-91. PubMed ID: 2416838
[TBL] [Abstract][Full Text] [Related]
7. Myogenesis in thymic transplants in the severe combined immunodeficient mouse model of myasthenia gravis. Differentiation of thymic myoid cells into striated muscle cells.
Spuler S; Marx A; Kirchner T; Hohlfeld R; Wekerle H
Am J Pathol; 1994 Oct; 145(4):766-70. PubMed ID: 7943168
[TBL] [Abstract][Full Text] [Related]
8. Effects of cytokines on acetylcholine receptor expression: implications for myasthenia gravis.
Poëa-Guyon S; Christadoss P; Le Panse R; Guyon T; De Baets M; Wakkach A; Bidault J; Tzartos S; Berrih-Aknin S
J Immunol; 2005 May; 174(10):5941-9. PubMed ID: 15879086
[TBL] [Abstract][Full Text] [Related]
9. Intrathymic pathogenesis of myasthenia gravis: transient expression of acetylcholine receptors on thymus-derived myogenic cells.
Wekerle H; Ketelsen UP; Zurn AD; Fulpius BW
Eur J Immunol; 1978 Aug; 8(8):579-82. PubMed ID: 699955
[TBL] [Abstract][Full Text] [Related]
10. Myoid cells and neuroendocrine markers in myasthenic thymuses.
Zółtowska A; Pawełczyk T; Stopa M; Skokowski J; Stepiński J; Roszkiewicz A; Nyka W
Arch Immunol Ther Exp (Warsz); 1998; 46(4):253-7. PubMed ID: 9779292
[TBL] [Abstract][Full Text] [Related]
11. Thymic myoid cells as a myasthenogenic antigen and antigen-presenting cells.
Matsumoto MY; Matsuo H; Oka T; Fukudome T; Hayashi K; Shiraishi H; Motomura M; Shibuya N; Ayabe H
J Neuroimmunol; 2004 May; 150(1-2):80-7. PubMed ID: 15081251
[TBL] [Abstract][Full Text] [Related]
12. Proteins with epitopes of the acetylcholine receptor in epithelial cell cultures of thymomas in myasthenia gravis.
Marx A; Kirchner T; Hoppe F; O'Connor R; Schalke B; Tzartos S; Müller-Hermelink HK
Am J Pathol; 1989 Apr; 134(4):865-77. PubMed ID: 2468286
[TBL] [Abstract][Full Text] [Related]
13. MHC class II presentation of human acetylcholine receptor in Myasthenia gravis: binding of synthetic gamma subunit sequences to DR molecules.
Yuen MH; Macklin KD; Conti-Fine BM
J Autoimmun; 1996 Feb; 9(1):67-77. PubMed ID: 8845056
[TBL] [Abstract][Full Text] [Related]
14. TCR V beta usage by acetylcholine receptor-specific CD4+ T cells in myasthenia gravis.
Raju R; Navaneetham D; Protti MP; Horton RM; Hoppe BL; Howard J; Conti-Fine BM
J Autoimmun; 1997 Apr; 10(2):203-17. PubMed ID: 9185882
[TBL] [Abstract][Full Text] [Related]
15. Are linear AChR epitopes the real culprit in ocular myasthenia gravis?
Wu X; Tüzün E
Med Hypotheses; 2017 Feb; 99():26-28. PubMed ID: 28110692
[TBL] [Abstract][Full Text] [Related]
16. Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG.
Leite MI; Ströbel P; Jones M; Micklem K; Moritz R; Gold R; Niks EH; Berrih-Aknin S; Scaravilli F; Canelhas A; Marx A; Newsom-Davis J; Willcox N; Vincent A
Ann Neurol; 2005 Mar; 57(3):444-8. PubMed ID: 15732104
[TBL] [Abstract][Full Text] [Related]
17. Myasthenia gravis.
Marx A; Schultz A; Wilisch A; Nenninger R; Müller-Hermelink HK
Verh Dtsch Ges Pathol; 1996; 80():116-26. PubMed ID: 9020569
[TBL] [Abstract][Full Text] [Related]
18. Pathogenetic significance of fetal-type acetylcholine receptors on thymic myoid cells in myasthenia gravis.
Geuder KI; Marx A; Witzemann V; Schalke B; Toyka K; Kirchner T; Müller-Hermelink HK
Dev Immunol; 1992; 2(2):69-75. PubMed ID: 1643420
[TBL] [Abstract][Full Text] [Related]
19. The myasthenia gravis thymus: a rare source of human autoantibody-secreting plasma cells for testing potential therapeutics.
Hill ME; Shiono H; Newsom-Davis J; Willcox N
J Neuroimmunol; 2008 Sep; 201-202():50-6. PubMed ID: 18722675
[TBL] [Abstract][Full Text] [Related]
20. Clonal heterogeneity of thymic B cells from early-onset myasthenia gravis patients with antibodies against the acetylcholine receptor.
Vrolix K; Fraussen J; Losen M; Stevens J; Lazaridis K; Molenaar PC; Somers V; Bracho MA; Le Panse R; Stinissen P; Berrih-Aknin S; Maessen JG; Van Garsse L; Buurman WA; Tzartos SJ; De Baets MH; Martinez-Martinez P
J Autoimmun; 2014 Aug; 52():101-12. PubMed ID: 24439114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
